Literature DB >> 22295162

Drug sensitivity testing for personalized lung cancer therapy.

Peter W Gout1, Yuzhuo Wang.   

Abstract

Entities:  

Year:  2012        PMID： 22295162      PMCID： PMC3256555          DOI： 10.3978/j.issn.2072-1439.2011.06.07

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  The tissue is the issue: personalized medicine for non-small cell lung cancer.

Authors:  Fred R Hirsch; Murry W Wynes; David R Gandara; Paul A Bunn
Journal:  Clin Cancer Res       Date:  2010-10-05       Impact factor: 12.531

2.  Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapy.

Authors:  Xin Dong; Jun Guan; John C English; Julia Flint; John Yee; Kenneth Evans; Nevin Murray; Calum Macaulay; Raymond T Ng; Peter W Gout; Wan L Lam; Janessa Laskin; Victor Ling; Stephen Lam; Yuzhuo Wang
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

3.  Personalized cancer therapy gets closer.

Authors:  Erika Check Hayden
Journal:  Nature       Date:  2009-03-12       Impact factor: 49.962

Review 4.  Genomic medicine in non-small cell lung cancer: paving the path to personalized care.

Authors:  Krishna Bajee Sriram; Jill Everland Larsen; Ian Anthony Yang; Rayleen Veronica Bowman; Kwun Meng Fong
Journal:  Respirology       Date:  2011-02       Impact factor: 6.424

Review 5.  Pathology of lung cancer.

Authors:  William D Travis
Journal:  Clin Chest Med       Date:  2002-03       Impact factor: 2.878

6.  Differences in chemosensitivity between primary and paired metastatic lung cancer tissues: In vitro analysis based on the collagen gel droplet embedded culture drug test (CD-DST).

Authors:  Masahiko Higashiyama; Jiro Okami; Jun Maeda; Toshiteru Tokunaga; Ayako Fujiwara; Ken Kodama; Fumio Imamura; Hisayuki Kobayashi
Journal:  J Thorac Dis       Date:  2012-02       Impact factor: 2.895

7.  Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.

Authors:  Dennis A Wigle; Igor Jurisica; Niki Radulovich; Melania Pintilie; Janet Rossant; Ni Liu; Chao Lu; James Woodgett; Isolde Seiden; Michael Johnston; Shaf Keshavjee; Gail Darling; Timothy Winton; Bobby-Joe Breitkreutz; Paul Jorgenson; Mike Tyers; Frances A Shepherd; Ming Sound Tsao
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

Review 8.  Exploring the genomes of cancer cells: progress and promise.

Authors:  Michael R Stratton
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

9.  Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.

Authors:  Bryan P Toole
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

10.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

Authors:  Jean-Pierre Pignon; Hélène Tribodet; Giorgio V Scagliotti; Jean-Yves Douillard; Frances A Shepherd; Richard J Stephens; Ariane Dunant; Valter Torri; Rafael Rosell; Lesley Seymour; Stephen G Spiro; Estelle Rolland; Roldano Fossati; Delphine Aubert; Keyue Ding; David Waller; Thierry Le Chevalier
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544
  10 in total
  2 in total

1.  Next generation patient-derived prostate cancer xenograft models.

Authors:  Dong Lin; Hui Xue; Yuwei Wang; Rebecca Wu; Akira Watahiki; Xin Dong; Hongwei Cheng; Alexander W Wyatt; Colin C Collins; Peter W Gout; Yuzhuo Wang
Journal:  Asian J Androl       Date:  2014 May-Jun       Impact factor: 3.285

2.  Design and construction of translational medicine platform for urologic oncology.

Authors:  Yong Xu; Kuo Yang
Journal:  Transl Androl Urol       Date:  2012-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.